Purple Biotech
PPBT
3 hedge funds and large institutions have $56K invested in Purple Biotech in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less funds holding
Funds holding: 6 → 3 (-3)
69% less capital invested
Capital invested by funds: $179K → $56K (-$123K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$25.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$67K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$29K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$10.1K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$5.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $23K | +$25.2K | +5 | New |
|
|
2
Wells Fargo
San Francisco,
California
| $22K | -$10.1K | -2 | -29% |
|
3
UBS Group
Zurich,
Switzerland
| $10K | – | – | – |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $1K | -$5.04K | -1 | Closed |
|
|
VF
5
Virtu Financial
New York
| – | -$67K | -15 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$38K | -8 | Closed |
|
|
OAM
7
Oxford Asset Management
Oxford,
United Kingdom
| – | -$29K | -6 | Closed |
|
PPBT Hedge Fund Activity: Q1 2018 in Review
3 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q1 2018, worth a combined $56K — down 69% from $179K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PPBT and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $25.2K. The largest seller was Virtu Financial, exiting entirely with an estimated $67K sold.
- 3 institutional investors held Purple Biotech (PPBT) as of Q1 2018, down from 6 in Q4 2017.
- Funds reported $56K of Purple Biotech stock for Q1 2018, down 69% quarter-over-quarter.
- 1 fund opened new Purple Biotech positions in Q1 2018 and 4 closed out, a net change of -3 holders.
- The largest Purple Biotech buyer in Q1 2018 was Two Sigma Securities, an estimated $25.2K added.
- The largest Purple Biotech seller in Q1 2018 was Virtu Financial, an estimated $67K sold.
Based on aggregated 13F filings for Q1 2018.